Search Results - "Zypchen, Leslie"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Fludarabine and rituximab for relapsed or refractory hairy cell leukemia by Gerrie, Alina S., Zypchen, Leslie N., Connors, Joseph M.

    Published in Blood (01-03-2012)
    “…The purine analogs, pentostatin and cladribine, induce high remission rates when used as first-line monotherapy for hairy cell leukemia (HCL); however,…”
    Get full text
    Journal Article
  2. 2

    Solvent-Detergent Plasma for the Treatment of Thrombotic Microangiopathies: A Canadian Tertiary Care Centre Experience by Lee, Lauren J., Roland, Kristine J., Sreenivasan, Gayatri M., Zypchen, Leslie N., Ambler, Kimberley L.S., Yenson, Paul R.

    Published in Transfusion and apheresis science (01-04-2018)
    “…Solvent detergent-treated plasma (SDP) is a pathogen-inactivated blood plasma, which in comparison to frozen plasma is associated with lower rates of allergic…”
    Get full text
    Journal Article
  3. 3

    Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin by Chen, Luke Y, Chang, Silvia D, Sreenivasan, Gayatri M, Tsang, Peter W, Broady, Raewyn C, Li, Charles H, Zypchen, Leslie N

    Published in Annals of hematology (01-02-2011)
    “…Hyperferritinemia is common in individuals with the metabolic syndrome (dysmetabolic hyperferritinemia), but its pathophysiology and the degree to which it…”
    Get full text
    Journal Article
  4. 4

    Macrocytosis in Mitochondrial DNA Deletion Syndromes by Almarzooqi, Farida, Vallance, Hilary, Mezei, Michelle, Lehman, Anna, Horvath, Gabriella, Rakic, Bojana, Zypchen, Leslie, Mattman, Andre

    Published in Acta haematologica (01-06-2023)
    “…Large single mitochondrial DNA (mtDNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among…”
    Get more information
    Journal Article
  5. 5

    Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline by Liu, David, Peterson, Erica, Dooner, James, Baerlocher, Mark, Zypchen, Leslie, Gagnon, Joel, Delorme, Michael, Sing, Chad Kim, Wong, Jason, Guzman, Randolph, Greenfield, Gavin, Moodley, Otto, Yenson, Paul

    “…Novel oral anticoagulants (rivaroxaban, dabigatran and apixaban) have also been shown to be effective for the treatment of acute DVT (see Appendix 2). Studies…”
    Get full text
    Journal Article
  6. 6

    Fludarabine and Rituximab (FR) Is a Safe and Effective Treatment Alternative for Relapsed or Refractory Hairy Cell Leukemia (HCL) by Gerrie, Alina S., Zypchen, Leslie N., Connors, Joseph M.

    Published in Blood (19-11-2010)
    “…Abstract 2454 Purine nucleoside analogs have been shown to produce high remission rates of 75–90% when used as first-line monotherapy for HCL. Long-term…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples by Smith, Tyler W., Zypchen, Leslie, Carter, Cedric J., Tran, Annie, Colley, Pamela, Gin, Kenneth, Teal, Philip, Masri, Bassam A., Lee, Agnes Y.Y.

    Published in Blood (16-11-2012)
    “…Abstract 23 To date, all published studies assessing the effects of the new oral anticoagulants dabigatran (dabi) and rivaroxaban (riva) on coagulation assays…”
    Get full text
    Journal Article
  9. 9

    Monoclonal Proteins in Elderly Patients with Osteoporosis by Ambler, Kimberley, Song, Kevin W., Dian, Larry, Zypchen, Leslie

    Published in Blood (16-11-2008)
    “…Background: Monoclonal proteins (M-proteins) and osteoporosis are both common in the elderly. For most patients with M-proteins and osteoporosis, the protein…”
    Get full text
    Journal Article
  10. 10

    High Dose Melphalan and Autologous Stem Cell Transplantation In Light Chain and Light and Heavy Chain Deposition Disease: Hematologic and Renal Outcomes by Telio, David, Shepherd, John, Forrest, Donna L., Barnett, Michael J., Nevill, Thomas J., Zypchen, Leslie, Song, Kevin

    Published in Blood (19-11-2010)
    “…Abstract 4597 Light chain deposition disease (LCDD) and light and heavy chain deposition disease (LHCDD) are plasma cell disorders characterized by pathologic…”
    Get full text
    Journal Article
  11. 11

    Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice by Lee, Vivian H Y, Peterson, Erica, Zypchen, Leslie, Foltz, Lynda M

    Published in Blood (20-11-2009)
    “…Abstract 1903 Poster Board I-926 The discovery of the JAK2 V617F gene mutation has significantly altered the clinical diagnostic approach to the…”
    Get full text
    Journal Article
  12. 12

    Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia by Peterson, Erica, Zypchen, Leslie, Nitta, Janet, Berkowitz, Jonathan, Foltz, Lynda M

    Published in Blood (20-11-2009)
    “…Abstract 2916 Poster Board II-892 Essential thrombocythemia (ET) is a myeloproliferative neoplasm associated with increased risk of both venous and arterial…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma by Ezzat, Hatoon, Filipenko, J. Doug, Vickars, Linda M., Galbraith, Paul F., Li, Charles H., Murphy, Kevin, Montaner, Julio, Harris, Marianne, Hogg, Robert, Vercauteren, Suzanne, Leger, Chantal S., Zypchen, Leslie, Leitch, Heather A.

    Published in Blood (16-11-2005)
    “…BCL-2 expression in diffuse large B cell lymphoma (DLBCL) in HIV-negative patients (pts) is associated with inferior outcome, an effect at least partially…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20